Abstract
Summary
1. Statolon, a broad spectrum antiviral agent, effectively inhibits the development of adjuvant-arthritis in Fischer strain rats. 2. It is suggested that a virus is involved in the pathogenesis of the disease, and it probably has some relationship to lymphoid cells. 3. Evidence against an anti-inflammatory or anti-immunological effect of statolon in adjuvant-arthritis is presented. 4. The possible participation of other factors in the pathogenesis of this experimental model of arthritis requires further study.
Get full access to this article
View all access options for this article.